drugset / Trial / NCT02329600

Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus

NCT02329600

Phase 3 Completed 40 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.

Timeline

Start
2013-06
Primary completion
2014-08
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject green tea extract Unknown 200 mg Oral
Background Triamcinolone Acetonide Other / unclassified Topical

Indications